Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Endometrial Neoplasms 4Endometrial Hyperplasia 2Overweight 1Obesity 1Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

Temozolomide 10Radiotherapy 5Radiation 4Magnetic Resonance Spectroscopy 4Ipilimumab 3pembrolizumab 2Specimen Handling 2Photons 2Nivolumab 2veliparib 1sargramostim 1peposertib 1montanide ISA 51 1liposomal doxorubicin 1cemiplimab 1balstilimab 1abexinostat 1X-Rays 1Vorinostat 1Utrogestan 1Surgical Procedures, Operative 1Sonication 1Progestins 1Progesterone 1Perfusion Magnetic Resonance Imaging 1Mycophenolic Acid 1Lomustine 1Irinotecan 1Drug Therapy 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Progestins × 90 days × Clear all
NCT05091866 2026-05-05

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Emory University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡